Granules India Limited (BOM:532482)
863.35
+8.95 (1.05%)
At close: Jul 7, 2026
Granules India Employees
Granules India had 4,066 employees as of March 31, 2025. The number of employees increased by 9 or 0.22% compared to the previous year.
Employees
4,066
Change (1Y)
9
Growth (1Y)
0.22%
Revenue / Employee
13.20M INR
Profits / Employee
1.46M INR
Market Cap
213.94B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,066 | 9 | 0.22% |
| Mar 31, 2024 | 4,057 | 407 | 11.15% |
| Mar 31, 2023 | 3,650 | -36 | -0.98% |
| Mar 31, 2022 | 3,686 | 317 | 9.41% |
| Mar 31, 2021 | 3,369 | 340 | 11.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 5,153 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,103 |
| Procter & Gamble Health | 1,326 |
| Viyash Scientific | 1,244 |
Granules India News
- 1 day ago - Granules India secures sole First-to-File status for generic drug - The Times of India
- 1 day ago - Granules India shares gain 2% after company secures Sole First-to-File status for Sodium Oxybate ANDA in US - Business Upturn
- 1 day ago - Granules India secures sole first-to-file ANDA status for sodium oxybate - Business Upturn
- 4 weeks ago - Granules India subsidiary receives USFDA EIR for Chantilly facility - Business Upturn
- 5 weeks ago - Why are Granules India shares up nearly 5% today? Block deal worth 15.3 lakh shares triggers buying interest - Business Upturn
- 2 months ago - Granules India Transcript: Q4 25/26 - Transcripts
- 2 months ago - Granules India Quarterly report: Q4 2026 - Filings
- 2 months ago - Granules India Slides: Q4 2026 - Filings